Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'CHOLECYSTOKININ-TETRAPEPTIDE' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 72 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Farook, JM; Zhu, YZ; Wang, H; Moochhala, S; Lee, L; Wong, PTH
      Strain differences in freezing behavior of PVG hooded and Sprague-Dawley rats: differential cortical expression of cholecystokinin(2) receptors

      NEUROREPORT
    2. Zwanzger, P; Baghai, TC; Schuele, C; Strohle, A; Padberg, F; Kathmann, N; Schwarz, M; Moller, HJ; Rupprecht, R
      Vigabatrin decreases cholecystokinin-tetrapeptide (CCK-4) induced panic inhealthy volunteers

      NEUROPSYCHOPHARMACOLOGY
    3. Le Melledo, JM; Jhangri, GS; Lott, P; Tait, GR; McManus, K; Geddes, M; Chrapko, W; Lara, N
      Effect of medroxyprogesterone pretreatment on pentagastrin-induced panic symptoms in females with panic disorder

      PSYCHIATRY RESEARCH
    4. Koszycki, D; Bradwejn, J
      Anxiety sensitivity does not predict fearful responding to 35% carbon dioxide in patients with panic disorder

      PSYCHIATRY RESEARCH
    5. McManus, K; Tait, GR; Bellavance, F; Le Melledo, JM
      Effect of ethinyl estradiol on the panic response to the panicogenic agentpentagastrin

      JOURNAL OF AFFECTIVE DISORDERS
    6. Gelernter, J; Bonvicini, K; Page, G; Woods, SW; Goddard, AW; Kruger, S; Pauls, DL; Goodson, S
      Linkage genome scan for loci predisposing to panic disorder or agoraphobia

      AMERICAN JOURNAL OF MEDICAL GENETICS
    7. Le Melledo, JM; Arthur, H; Dalton, J; Woo, C; Lipton, N; Bellavance, F; Koszycki, D; Boulenger, JP; Bradwejn, J
      The influence of Type A behavior pattern on the response to the panicogenic agent CCK-4

      JOURNAL OF PSYCHOSOMATIC RESEARCH
    8. Strohle, A; Kellner, M; Holsboer, F; Wiedemann, K
      Anxiolytic activity of atrial natriuretic peptide in patients with panic disorder

      AMERICAN JOURNAL OF PSYCHIATRY
    9. Strohle, A; Holsboer, F; Rupprecht, R
      Increased ACTH concentrations associated with cholecystokinin tetrapeptide-induced panic attacks in patients with panic disorder

      NEUROPSYCHOPHARMACOLOGY
    10. Flint, AJ; Koszycki, D; Bradwejn, J; Vaccarino, FJ
      Neurohormonal responses to cholecystokinin tetrapeptide: a comparison of younger and older healthy subjects

      PSYCHONEUROENDOCRINOLOGY
    11. Singewald, N; Sharp, T
      Neuroanatomical targets of anxiogenic drugs in the hindbrain as revealed by Fos immunocytochemistry

      NEUROSCIENCE
    12. Bradwejn, J; Zhou, YP; Koszycki, D; Shlik, J
      A double-blind, placebo-controlled study on the effects of Gotu Kola (Centella asiatica) on acoustic startle response in healthy subjects

      JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
    13. Tavernor, SJ; Abduljawad, KAJ; Langley, RW; Bradshaw, CM; Szabadi, E
      Effects of pentagastrin and the cold presser test on the acoustic startle response and pupillary function in man

      JOURNAL OF PSYCHOPHARMACOLOGY
    14. Sandford, JJ; Argyropoulos, SV; Nutt, DJ
      The psychobiology of anxiolytic drugs - Part 1: basic neurobiology

      PHARMACOLOGY & THERAPEUTICS
    15. Strohle, A
      Increased response to a putative panicogenic nocebo administration in female patients with panic disorder

      JOURNAL OF PSYCHIATRIC RESEARCH
    16. Kellner, M; Wiedemann, K; Yassouridis, A; Levengood, R; Guo, LS; Holsboer, F; Yehuda, R
      Behavioral and endocrine response to cholecystokinin tetrapeptide in patients with posttraumatic stress disorder

      BIOLOGICAL PSYCHIATRY
    17. Cohen, H; Kaplan, Z; Kotler, M
      CCK-antagonists in a rat exposed to acute stress: Implication for anxiety associated with post-traumatic stress disorder

      DEPRESSION AND ANXIETY
    18. Jerabek, I; Boulenger, JP; Bradwejn, J; Lavallee, YJ; Jolicoeur, FB
      CCK4-induced panic in healthy subjects I: psychological and cardiovasculareffects

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    19. Jerabek, I; Boulenger, JP; Bradwejn, J; Drumheller, A; Lavallee, YJ; Jolicoeur, FB
      CCK4-induced panic in healthy subjects II: neurochemical correlates

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    20. Blier, P; de Montigny, C
      Serotonin and drug-induced therapeutic responses in major depression, obsessive-compulsive and panic disorders

      NEUROPSYCHOPHARMACOLOGY
    21. Depot, M; Caille, G; Mukherjee, J; Katzman, MA; Cadieux, A; Bradwejn, J
      Acute and chronic role of 5-HT3 neuronal system on behavioral and neuroendocrine changes induced by intravenous cholecystokinin tetrapeptide administration in humans

      NEUROPSYCHOPHARMACOLOGY
    22. LEMELLEDO JM; MERANI S; KOSZYCKI D; BELLAVANCE F; PALMOUR R; GUTKOWSKA J; STEINBERG S; BICHET DG; BRADWEJN J
      SENSITIVITY TO CCK-4 IN WOMEN WITH AND WITHOUT PREMENSTRUAL DYSPHORICDISORDER (PMDD) DURING THEIR FOLLICULAR AND LUTEAL PHASES

      Neuropsychopharmacology
    23. Leonard, BE
      New developments in the pharmacological treatment of anxiety

      HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
    24. Shlik, J; Zhou, YP; Koszycki, D; Vaccarino, FJ; Bradwejn, J
      Effects of CCK-4 infusion on the acoustic eye-blink startle and psychophysiological measures in healthy volunteers

      JOURNAL OF PSYCHOPHARMACOLOGY
    25. Goddard, AW; Woods, SW; Money, R; Pande, AC; Charney, DS; Goodman, WK; Heninger, GR; Price, LH
      Effects of the CCKB antagonist CI-988 on responses to mCPP in generalized anxiety disorder

      PSYCHIATRY RESEARCH
    26. To, CT; Bagdy, G
      Anxiogenic effect of central CCK administration is attenuated by chronic fluoxetine or ipsapirone treatment

      NEUROPHARMACOLOGY
    27. Javanmard, M; Shlik, J; Kennedy, SH; Vaccarino, FJ; Houle, S; Bradwejn, J
      Neuroanatomic correlates of CCK-4-induced panic attacks in healthy humans:A comparison of two time points

      BIOLOGICAL PSYCHIATRY
    28. Benjamin, J; Geraci, M; McCann, U; Greenberg, BD; Murphy, DL
      Attenuated response to m-CPP and to pentagastrin after repeated m-CPP in panic disorder

      PSYCHOPHARMACOLOGY
    29. GADEA M; ESPERT R; NAVARRO JF
      BIOLOGICAL BASIS OF PANIC DISORDER

      Psicologia conductual
    30. JERABEK I; BOULENGER JP; LAVALLEE YJ; JOLICOEUR FB
      PSYCHOLOGICAL PREDICTORS OF CCK4-INDUCED PANIC-LIKE SYMPTOMS

      Human psychopharmacology
    31. DENBOER JA; SLAAP BR
      REVIEW OF CURRENT TREATMENT IN PANIC DISORDER

      International clinical psychopharmacology
    32. SHLIK J; KOSZYCKI D; BRADWEJN J
      DECREASE IN SHORT-TERM-MEMORY FUNCTION INDUCED BY CCK-4 IN HEALTHY-VOLUNTEERS

      Peptides (New York, N.Y. 1980)
    33. GARVEY MJ; CROWE RR; WANG ZW
      AN ASSOCIATION OF NAG LEVELS AND A MUTATION OF THE CCK GENE IN PANIC DISORDER PATIENTS

      Psychiatry research
    34. Akiyoshi, J; Yamauchi, C; Furuta, M; Katsuragi, S; Kohno, Y; Yamamoto, Y; Miyamoto, M; Tsutsumi, T; Isogawa, K; Fujii, I
      Relationship between SCL-90, Maudsley Personality Inventory and CCK4-induced intracellular calcium response in T cells

      PSYCHIATRY RESEARCH
    35. DESOUSA NJ; WUNDERLICH GR; DECABO C; VACCARINO FJ
      INDIVIDUAL-DIFFERENCES IN SUCROSE INTAKE PREDICT BEHAVIORAL REACTIVITY IN RODENT MODELS OF ANXIETY

      Pharmacology, biochemistry and behavior
    36. GRIEZ E; SCHRUERS K
      EXPERIMENTAL PATHOPHYSIOLOGY OF PANIC

      Journal of psychosomatic research
    37. Kuribara, H; Stavinoha, WB; Maruyama, Y
      Behavioural pharmacological characteristics of honokiol, an anxiolytic agent present in extracts of Magnolia bark, evaluated by an elevated plus-mazetest in mice

      JOURNAL OF PHARMACY AND PHARMACOLOGY
    38. MCCANN UD; MORGAN CM; GERACI M; SLATE SO; MURPHY DL; POST RM
      EFFECTS OF THE 5-HT3 ANTAGONIST, ONDANSETRON, ON THE BEHAVIORAL AND PHYSIOLOGICAL-EFFECTS OF PENTAGASTRIN IN PATIENTS WITH PANIC DISORDER AND SOCIAL PHOBIA

      Neuropsychopharmacology
    39. MCCANN UD; SLATE SO; GERACI M; ROSCOWTERRILL D; UHDE TW
      A COMPARISON OF THE EFFECTS OF INTRAVENOUS PENTAGASTRIN ON PATIENTS WITH SOCIAL PHOBIA, PANIC DISORDER AND HEALTHY CONTROLS

      Neuropsychopharmacology
    40. MATTO V; HARRO J; ALLIKMETS L
      THE EFFECT OF DRUGS ACTING ON CCK RECEPTORS AND RAT FREE EXPLORATION IN THE EXPLORATION BOX

      Journal of Physiology and Pharmacology
    41. GODDARD AW; CHARNEY DS
      TOWARD AN INTEGRATED NEUROBIOLOGY OF PANIC DISORDER

      The Journal of clinical psychiatry
    42. SHIOSAKI K; LIN CW; KOPECKA H; BIANCHI B; MILLER T; STASHKO M; WITTE D
      MINOR STRUCTURAL DIFFERENCES IN BOC-CCK-4 DERIVATIVES DICTATE AFFINITY AND SELECTIVITY FOR CCK-A AND CCK-B RECEPTORS

      Journal of medicinal chemistry
    43. OLIVER AS; VIGNA SR
      CCK-A-LIKE AND CCK-B-LIKE RECEPTORS IN THE GALLBLADDER AND STOMACH OFTHE ALLIGATOR (ALLIGATOR-MISSISSIPPIENSIS)

      General and comparative endocrinology
    44. BALLAZ S; BARBER A; FORTUNO A; DELRIO J; MARTINMARTINEZ M; GOMEZMONTERREY I; HERRANZ R; GONZALEZMUNIZ R; GARCIALOPEZ MT
      PHARMACOLOGICAL EVALUATION OF IQM-95,333, A HIGHLY SELECTIVE CCKA RECEPTOR ANTAGONIST WITH ANXIOLYTIC-LIKE ACTIVITY IN ANIMAL-MODELS

      British Journal of Pharmacology
    45. SHLIK J; VASAR V; ALUOJA A; KINGISEPP PH; JAGOMAGI K; VASAR E; RAGO L; BRADWEJN J
      THE EFFECT OF CHOLECYSTOKININ TETRAPEPTIDE ON RESPIRATORY RESISTANCE IN HEALTHY-VOLUNTEERS

      Biological psychiatry
    46. PALMOUR RM; MULLIGAN J; HOWBERT JJ; ERVIN F
      OF MONKEYS AND MEN - VERVETS AND THE GENETICS OF HUMAN-LIKE BEHAVIORS

      American journal of human genetics
    47. VANMEGEN HJGM; WESTENBERG HGM; DENBOER JA; SLAAP B; SCHEEPMAKERS A
      EFFECT OF THE SELECTIVE SEROTONIN REUPTAKE INHIBITOR FLUVOXAMINE ON CCK-4 INDUCED PANIC ATTACKS

      Psychopharmacology
    48. JENCK F; MARTIN JR; MOREAU JL
      BEHAVIORAL-EFFECTS OF CCKB RECEPTOR LIGANDS IN A VALIDATED SIMULATIONOF PANIC ANXIETY IN RATS

      European neuropsychopharmacology
    49. TELCH MJ; SILVERMAN A; SCHMIDT NB
      EFFECTS OF ANXIETY SENSITIVITY AND PERCEIVED CONTROL ON EMOTIONAL RESPONDING TO CAFFEINE CHALLENGE

      Journal of anxiety disorders
    50. WENG JH; BADO A; GARBAY C; ROQUES BP
      NOVEL CCK-B RECEPTOR AGONISTS - DIKETOPIPERAZINE ANALOGS DERIVED FROMCCK4 BIOACTIVE CONFORMATION

      Regulatory peptides
    51. KRYSTAL JH; DEUTSCH DN; CHARNEY DS
      THE BIOLOGICAL BASIS OF PANIC DISORDER

      The Journal of clinical psychiatry
    52. DUNLOP J; BRAMMER N; ENNIS C
      PHARMACOLOGICAL CHARACTERIZATION OF A CHINESE-HAMSTER OVARY CELL-LINETRANSFECTED WITH THE HUMAN CCK-B RECEPTOR GENE

      Neuropeptides
    53. AKIYOSHI J; MORIYAMA T; ISOGAWA K; MIYAMOTO M; SASAKI I; KUGA K; YAMAMOTO H; YAMADA K; FUJII I
      CCK-4-INDUCED CALCIUM MOBILIZATION IN T-CELLS IS ENHANCED IN PANIC DISORDER

      Journal of neurochemistry
    54. OLIVER AS; VIGNA SR
      CCK-X RECEPTORS IN THE ENDOTHERMIC MAKO SHARK (ISURUS-OXYRINCHUS)

      General and comparative endocrinology
    55. IZUMI T; INOUE T; TSUCHIYA K; HASHIMOTO S; OHMORI T; KOYAMA T
      EFFECT OF THE SELECTIVE CCKB RECEPTOR ANTAGONIST LY288513 ON CONDITIONED FEAR STRESS IN RATS

      European journal of pharmacology
    56. FRANKLAND PW; JOSSELYN SA; BRADWEJN J; VACCARINO FJ; YEOMANS JS
      INTRACEREBROVENTRICULAR INFUSION OF THE CCKB RECEPTOR AGONIST PENTAGASTRIN POTENTIATES ACOUSTIC STARTLE

      Brain research
    57. HARRINGTON PJ; SCHMIDT NB; TELCH MJ
      PROSPECTIVE EVALUATION OF PANIC POTENTIATION FOLLOWING 35-PERCENT CO2CHALLENGE IN NONCLINICAL SUBJECTS

      The American journal of psychiatry
    58. DELEEUW AS; DENBOER JA; SLAAP BR; WESTENBERG HGM
      PENTAGASTRIN HAS PANIC INDUCING PROPERTIES IN OBSESSIVE-COMPULSIVE DISORDER

      Psychopharmacology
    59. ADAMS JB; PYKE RE; COSTA J; CUTLER NR; SCHWEIZER E; WILCOX CS; WISSELINK PG; GREINER M; PIERCE MW; PANDE AC
      A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF A CCK-B RECEPTOR ANTAGONIST, CI-988, IN PATIENTS WITH GENERALIZED ANXIETY DISORDER

      Journal of clinical psychopharmacology
    60. KUNOVAC JL; STAHL SM
      FUTURE-DIRECTIONS IN ANXIOLYTIC PHARMACOTHERAPY

      The Psychiatric clinics of North America
    61. BOURIN M; MALINGE M; GUITTON B
      PROVOCATIVE AGENTS IN PANIC DISORDER

      Therapie
    62. BENKELFAT C; BRADWEJN J; MEYER E; ELLENBOGEN M; MILOT S; GJEDDE A; EVANS A
      FUNCTIONAL NEUROANATOMY OF CCK4-INDUCED ANXIETY IN NORMAL HEALTHY-VOLUNTEERS

      The American journal of psychiatry
    63. CHARRIER D; DANGOUMAU L; PUECH AJ; HAMON M; THIEBOT MH
      FAILURE OF CCK RECEPTOR LIGANDS TO MODIFY ANXIETY-RELATED BEHAVIORAL SUPPRESSION IN AN OPERANT CONFLICT PARADIGM IN RATS

      Psychopharmacology
    64. MCCANN UD; SLATE SO; GERACI M; UHDE TW
      PEPTIDES AND ANXIETY - A DOSE-RESPONSE EVALUATION OF PENTAGASTRIN IN HEALTHY-VOLUNTEERS

      Anxiety
    65. UHDE TW
      ANXIETY AND GROWTH DISTURBANCE - IS THERE A CONNECTION - A REVIEW OF BIOLOGICAL STUDIES IN SOCIAL PHOBIA

      The Journal of clinical psychiatry
    66. ITOH S; KATSUURA G; ITOH T; MORIMOTO T
      REVERSED BEHAVIORAL-EFFECT OF CHOLECYSTOKININ AFTER FRONTAL DECORTICATION IN RATS

      Life sciences
    67. BIANCHI BR; MILLER TR; WITTE DG; LIN CW
      NOVEL CCK ANALOGS AND BOMBESIN - A DETAILED ANALYSIS BETWEEN PHOSPHOINOSITIDE BREAKDOWN AND HIGH-DOSE INHIBITION OF PANCREATIC-ENZYME SECRETION IN 3 RODENT SPECIES

      The Journal of pharmacology and experimental therapeutics
    68. KARIYA K; TANAKA J; NOMURA M
      SYSTEMIC ADMINISTRATION OF CCK-8S, BUT NOT CCK-4, ENHANCES DOPAMINE TURNOVER IN THE POSTERIOR NUCLEUS-ACCUMBENS - A MICRODIALYSIS STUDY IN FREELY MOVING RATS

      Brain research
    69. ABELSON JL; NESSE RM
      PENTAGASTRIN INFUSIONS IN PATIENTS WITH PANIC DISORDER .1. SYMPTOMS AND CARDIOVASCULAR-RESPONSES

      Biological psychiatry
    70. ABELSON JL; NESSE RM; VINIK AI
      PENTAGASTRIN INFUSIONS IN PATIENTS WITH PANIC DISORDER .2. NEUROENDOCRINOLOGY

      Biological psychiatry
    71. RUPNIAK NMJ; SCHAFFER L; SIEGL P; IVERSEN SD
      FAILURE OF INTRAVENOUS PENTAGASTRIN CHALLENGE TO INDUCE PANIC-LIKE EFFECTS IN RHESUS-MONKEYS

      Neuropeptides
    72. HARRO J; VASAR E; BRADWEJN J
      CCK IN ANIMAL AND HUMAN RESEARCH ON ANXIETY

      Trends in pharmacological sciences


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 20/01/21 alle ore 21:02:40